Dr. Frith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 Entrance Way
# Dv
Saint Peters, MO 63376Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2012 - 2015
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2011
- University of Arkansas For Medical Sciences College of MedicineClass of 2008
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 2013 - 2026
- TN State Medical License 2010 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsGenomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.Andrew A Davis, Jingqin Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong
Clinical Cancer Research. 2023-05-01 - 3 citationsA phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo
NPJ Breast Cancer. 2023-01-06 - 3 citationsA phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis.Jairam Krishnamurthy, Jingqin Luo, Rama Suresh, Foluso Ademuyiwa, Caron Rigden
NPJ Breast Cancer. 2022-03-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: